A pharmaceutical company that allegedly paid doctors kickbacks to push their HIV/AIDS drugs has agreed to pay a fine of more than $200 million to settle a civil lawsuit filed by federal prosecutors.
The government alleged that Gilead had induced doctors to prescribe a slew of HIV/AIDS drugs in exchange for honoraria payments, meals, and travel expenses to healthcare practitioners. Prosecutors said the company created a scheme where healthcare practitioners who spoke at or attended Gilead speaker events, and used the events as a a way to deliver kickbacks.
